Clarian venture fund invests in Minnesota firm
Clarian Health Ventures has invested an undisclosed amount of money in NeoChord Inc., a Minneapolis company that’s developing a treatment for mitral-valve regurgitation. The treatment is based on technology first developed at Mayo Clinic and has since received funding by angel investors with ties to Indianapolis, Clarian said in a press release. The technology has […]